The Pharmacogenomics of Hydroxyurea in Sickle Cell Disease

Institution(s): 
University of Texas Health at Houston
Approx. Sample Size to be Sequenced: 
1454

Project:

Disease/Phenotype: 

sickle cell disease

PI: 
Eric Boerwinkle
NIH Program Officer: 
Starting Phase: 
Phase 2
Phases Involved: 
2
6
Co-PI: 
Vivien Sheehan
Phenotype Liaison: 
Short Name: 
PharmHU
Sequencing Center(s) Phase 2: 
Baylor College of Medicine Human Genome Sequencing Center
Type of Sequencing: 
WGS
RNASeq
Sequencing External Funding: 
TOPMed Accession #: 
Omics Center(s) Phase 6: 
Northwest Genomics Center